Hospira Opens New Quality Laboratory at North Carolina Plant

Article

Hospira opens a new quality and analytical testing laboratory at its Rocky Mount, North Carolina plant.

Hospira, a provider of injectable drugs and infusion technologies, opened a new quality and analytical testing laboratory at its site in Rocky Mount, North Carolina. The new laboratory is part of a more than $200-million investment at Rocky Mount site, which includes further capital investments. This new quality laboratory will be home to 200 employees, responsible for evaluating and testing more than 450 different products.

The Rocky Mount site, which encompasses more than 1.4 million ft2, provides injectable manufacturing with various technologies, including isolator filling lines and form, fill, and seal operations. The primary product families manufactured at the plant include irrigation and intravenous (I.V.) solutions, renal and cardiovascular care products, therapeutics, local and general anesthesia, analgesia and anti-infectives. Most products are available in a variety of dosage strengths.

Source: Hospira

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.